Recent Posts

1. 

   Worst RBM’s at ICT

   Intra-Cellular Therapies

   anonymous

   Apr 18, 2024 at 9:25 PM

2. 

   Oncology Hybrid positions

   I see new Oncology hybrid positions posted along with something similar for Biosimilar roles. Are these all the same contract? Anyone know details of what company? Length of contract? Is it expected to be more of a field role with some downtime...

   Amplity

   anonymous

   Apr 18, 2024 at 9:24 PM

3. 

   This Company is a Complete Joke

   Bear

   Ironshore Pharmaceuticals

   anonymous

   Apr 18, 2024 at 9:14 PM

4. 

   Poll

   Please vote

   Thea Pharma

   anonymous

   Apr 18, 2024 at 9:04 PM

5. 

   Beigene

   Has the culture improved?

   Biotech Startups

   anonymous

   Apr 18, 2024 at 9:03 PM

6. 

   25 by 25

   I remember a simpler time when we thought 25 x 25 meant that there would be 25 new medicines on the market by the year 2025… we’ve been duped, why the stock is back at a 10 year low. With a 10 year low, Albert‘s gotta go.

   Pfizer

   anonymous

   Apr 18, 2024 at 9:02 PM

7. 

   Kaleo can't stay out of trouble

   Name them. Rank them. I call bs

   Kaleo Pharma

   anonymous

   Apr 18, 2024 at 8:54 PM

8. + Show More